Vicente Anido, Jr.
2014
In 2014, Vicente Anido, Jr. earned a total compensation of $5.3M as Chief Executive Officer & Chairman of the Board at Aerie Pharmaceuticals, a 36% decrease compared to previous year.
Compensation breakdown
| Bonus | $386,250 |
|---|---|
| Option Awards | $4,358,866 |
| Salary | $507,000 |
| Total | $5,252,116 |
Anido received $4.4M in option awards, accounting for 83% of the total pay in 2014.
Anido also received $386.3K in bonus and $507K in salary.
Rankings
In 2014, Vicente Anido, Jr.'s compensation ranked 1,459th out of 13,032 executives tracked by ExecPay. In other words, Anido earned more than 88.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,459 out of 13,032 | 89th |
Division Manufacturing | 526 out of 4,967 | 89th |
Major group Chemicals And Allied Products | 164 out of 1,690 | 90th |
Industry group Drugs | 129 out of 1,369 | 91st |
Industry Biological Products, Except Diagnostic Substances | 16 out of 241 | 93rd |
Source: SEC filing on April 29, 2016.
Anido's colleagues
We found three more compensation records of executives who worked with Vicente Anido, Jr. at Aerie Pharmaceuticals in 2014.
News
Aerie Pharmaceuticals CEO Vicente Anido's 2021 pay rises 4% to $3.8M
April 26, 2022
Aerie Pharmaceuticals CEO Vicente Anido's 2020 pay falls 35% to $3.6M
April 27, 2021
Aerie Pharmaceuticals CEO Vicente Anido's 2019 pay slips 18% to $5.5M
April 24, 2020
Aerie Pharmaceuticals CEO Vicente Anido's 2018 pay falls 33% to $6.8M
April 10, 2019